Portal vein thrombosis risk factors: Difference between revisions

Jump to navigation Jump to search
Line 24: Line 24:
*Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
*Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].
===Common Risk Factors===
===Common Risk Factors===
*Common risk factors in the development of toxic megacolon include:<ref name="SogaardAstrup2007">{{cite journal|last1=Sogaard|first1=Kirstine K|last2=Astrup|first2=Lone B|last3=Vilstrup|first3=Hendrik|last4=Gronbaek|first4=Henning|title=Portal vein thrombosis; risk factors, clinical presentation and treatment|journal=BMC Gastroenterology|volume=7|issue=1|year=2007|issn=1471-230X|doi=10.1186/1471-230X-7-34}}</ref>
*Common risk factors in the development of toxic megacolon include:<ref name="SogaardAstrup2007">{{cite journal|last1=Sogaard|first1=Kirstine K|last2=Astrup|first2=Lone B|last3=Vilstrup|first3=Hendrik|last4=Gronbaek|first4=Henning|title=Portal vein thrombosis; risk factors, clinical presentation and treatment|journal=BMC Gastroenterology|volume=7|issue=1|year=2007|issn=1471-230X|doi=10.1186/1471-230X-7-34}}</ref><ref name="pmid20474001">{{cite journal |vauthors=Kinjo N, Kawanaka H, Akahoshi T, Tomikawa M, Yamashita N, Konishi K, Tanoue K, Shirabe K, Hashizume M, Maehara Y |title=Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension |journal=Br J Surg |volume=97 |issue=6 |pages=910–6 |year=2010 |pmid=20474001 |doi=10.1002/bjs.7002 |url=}}</ref><ref name="pmid25941431">{{cite journal |vauthors=Chawla YK, Bodh V |title=Portal vein thrombosis |journal=J Clin Exp Hepatol |volume=5 |issue=1 |pages=22–40 |year=2015 |pmid=25941431 |pmc=4415192 |doi=10.1016/j.jceh.2014.12.008 |url=}}</ref><ref name="pmid28621635">{{cite journal |vauthors=Montenovo M, Rahnemai-Azar A, Reyes J, Perkins J |title=Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant |journal=Exp Clin Transplant |volume= |issue= |pages= |year=2017 |pmid=28621635 |doi=10.6002/ect.2016.0277 |url=}}</ref><ref name="pmid2806552">{{cite journal |vauthors=Zhang WW, Churchill S, Churchill P |title=Developmental regulation of D-beta-hydroxybutyrate dehydrogenase in rat liver and brain |journal=FEBS Lett. |volume=256 |issue=1-2 |pages=71–4 |year=1989 |pmid=2806552 |doi= |url=}}</ref>
**Prothrombotic disorder  
**Prothrombotic disorder  
***Hyperhomocysteinemia  
***Hyperhomocysteinemia  

Revision as of 20:50, 28 November 2017

Portal vein thrombosis Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Portal vein thrombosis from other Diseases

Epidemiology and Demographics

Risk Factors

Screening

Natural History, Complications and Prognosis

Diagnosis

Diagnostic Study of Choice

History and Symptoms

Physical Examination

Laboratory Findings

Electrocardiogram

X Ray

CT

MRI

Echocardiography or Ultrasound

Other Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Surgery

Primary Prevention

Secondary Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Portal vein thrombosis risk factors On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Portal vein thrombosis risk factors

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Portal vein thrombosis risk factors

CDC on Portal vein thrombosis risk factors

Portal vein thrombosis risk factors in the news

Blogs on Portal vein thrombosis risk factors

Directions to Hospitals Treating Portal vein thrombosis

Risk calculators and risk factors for Portal vein thrombosis risk factors

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief:

Overview

There are no established risk factors for [disease name].

OR

The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

OR

Common risk factors in the development of [disease name] may be occupational, environmental, genetic, and viral.

Risk Factors

  • There are no established risk factors for [disease name].

OR

  • The most potent risk factor in the development of [disease name] is [risk factor 1]. Other risk factors include [risk factor 2], [risk factor 3], and [risk factor 4].
  • Common risk factors in the development of [disease name] include [risk factor 1], [risk factor 2], [risk factor 3], and [risk factor 4].

Common Risk Factors

  • Common risk factors in the development of toxic megacolon include:[1][2][3][4][5]
    • Prothrombotic disorder
      • Hyperhomocysteinemia
      • Antiphospholipid syndrome
      • Hormone replacement therapy
      • Factor V Leiden mutation
      • Protein C deficiency
      • Polycythaemia vera
      • Myeloproliferative syndrome
      • Protein S deficiency
      • Antitrombin III deficiency
      • Disseminated coagulation
      • Essential thrombocytosis
    • Abdominal inflammation
      • Chronic pancreatitis
      • Cholangitis
      • Acute pancreatitis
      • Liver abscesses
      • mbilical vein catheterization
      • Cholecystolithiasis
      • Polycystic liver disease
    • Cirrhosis

Less Common Risk Factors

  • Less common risk factors in the development of [disease name] include:
    • Cancer
      • Neuro-endocrine tumor
      • Hepatocellular carcinoma
      • Pancreatic cancer
      • Angiomyxoma
      • Unknown primary tumour
    • Abdominal intervention
      • Splenectomy
      • Cholecystectomy
      • Billroth II
      • Radiofrequency ablation
      • Gastropancreaticcystotomy
    • Abdominal infection
      • Bacteraemia
      • Portal vein phlebitis
      • Intestinal tuberculosis
      • Sepsis
      • Tuberculosis in psoas abscess

References

  1. Sogaard, Kirstine K; Astrup, Lone B; Vilstrup, Hendrik; Gronbaek, Henning (2007). "Portal vein thrombosis; risk factors, clinical presentation and treatment". BMC Gastroenterology. 7 (1). doi:10.1186/1471-230X-7-34. ISSN 1471-230X.
  2. Kinjo N, Kawanaka H, Akahoshi T, Tomikawa M, Yamashita N, Konishi K, Tanoue K, Shirabe K, Hashizume M, Maehara Y (2010). "Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension". Br J Surg. 97 (6): 910–6. doi:10.1002/bjs.7002. PMID 20474001.
  3. Chawla YK, Bodh V (2015). "Portal vein thrombosis". J Clin Exp Hepatol. 5 (1): 22–40. doi:10.1016/j.jceh.2014.12.008. PMC 4415192. PMID 25941431.
  4. Montenovo M, Rahnemai-Azar A, Reyes J, Perkins J (2017). "Clinical Impact and Risk Factors of Portal Vein Thrombosis for Patients on Wait List for Liver Transplant". Exp Clin Transplant. doi:10.6002/ect.2016.0277. PMID 28621635.
  5. Zhang WW, Churchill S, Churchill P (1989). "Developmental regulation of D-beta-hydroxybutyrate dehydrogenase in rat liver and brain". FEBS Lett. 256 (1–2): 71–4. PMID 2806552.

Template:WH Template:WS